{
  "id": 8947972,
  "title": "Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock Movers",
  "url": "https://urgent.news/2026/09/21/accenture-up-on-partnership-with-anthropic-novo-nordisk-falls-on",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-21T14:49:08.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-09-21/accenture-anthropic-partnership-novo-nordisk-falls-video"
  },
  "original_language": "en",
  "account": null,
  "summary": "On this episode of Stock Movers: - Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}